Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Hospital Dr. Roberto del Río, Santiago, Chile.
Sci Rep. 2017 May 11;7(1):1795. doi: 10.1038/s41598-017-01896-w.
22q11.2 microdeletion syndrome (22q11.2DS) is the most common microdeletion disorder in humans, with an incidence of 1/4000 live births. It is caused by a heterozygous deletion of 1.5-3 Mb on chromosome region 22q11.2. Patients with the deletion present features that include neuropsychiatric problems, craniofacial abnormalities and cardiovascular malformations. However, the phenotype is highly variable and the factors related to the clinical heterogeneity are not fully understood. About 65% of patients with 22q11.2DS have congenital heart defects (CHD). The main goal of this study was to identify common CNVs in 22q11.2DS patients that could be associated with the incomplete penetrance of CHD. Analysis of genomic DNA from 253 patients with 22q11.2DS using array technology showed an association between a microduplication located in region 17q21.31 and CHD (p-value = 0.023, OR = 2.75, 95% CI = 1.17-7.03). This region includes the first three exons of KANSL1 gene. Bioinformatic analysis showed that KANSL1 and CRKL, a gene in the commonly deleted region of 22q11.2DS, are part of the same regulatory module in a miRNA-mRNA network. These results show that a KANSL1 microduplication, in combination with the 22q11.2 deletion, is associated with increased risk of CHD in these patients, suggesting that KANSL1 plays a role as a modifier gene in 22q11.2DS patients.
22q11.2 微缺失综合征(22q11.2DS)是人类最常见的微缺失疾病,发病率为 1/4000 活产儿。它是由染色体 22q11.2 区域上的杂合性缺失 1.5-3Mb 引起的。缺失的患者表现出神经精神问题、颅面异常和心血管畸形等特征。然而,表型高度可变,与临床异质性相关的因素尚未完全了解。大约 65%的 22q11.2DS 患者患有先天性心脏病(CHD)。本研究的主要目的是鉴定 22q11.2DS 患者中与 CHD 不完全外显相关的常见 CNV。使用阵列技术对 253 名 22q11.2DS 患者的基因组 DNA 进行分析,结果显示位于 17q21.31 区域的微重复与 CHD 相关(p 值=0.023,OR=2.75,95%CI=1.17-7.03)。该区域包含 KANSL1 基因的前三个外显子。生物信息学分析表明,KANSL1 和 CRKL,22q11.2DS 常见缺失区域的一个基因,是 miRNA-mRNA 网络中同一个调控模块的一部分。这些结果表明,KANSL1 微重复与 22q11.2 缺失相结合,与这些患者患 CHD 的风险增加相关,这表明 KANSL1 作为 22q11.2DS 患者的修饰基因发挥作用。